International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Doxepin Hydrochloride 5% in Cetaphil Cream

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2020 - Volume 24, Number 4
View All Articles in Issue

Page(s): 314

Doxepin Hydrochloride 5% in Cetaphil Cream Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Doxepin Hydrochloride 5% in Cetaphil Cream. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, doxepin hydrochloride, topical preparation, tricyclic antidepressant, depression, sedation, sedative, antimuscarinic agent

Related Categories: FORMULATIONS, MENTAL HEALTH, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Doxepin Hydrochloride 5% in Cetaphil Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 314
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Capsaicin 0.025% and Doxepin 3.3% Cream Allen Loyd V Jr	Nov/Dec 2016 Pg. 506
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Riepl Mike	Nov/Dec 2022 Pg. 480-488
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 482-490
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Allen Loyd V Jr	Jul/Aug 2020 Pg. 320
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 157
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2013 Pg. 502
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 418
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2024 Pg. 131
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	May/Jun 2016 Pg. 231
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	Mar/Apr 2024 Pg. 135
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Allen Loyd V Jr	May/Jun 2017 Pg. 234
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott	Mar/Apr 2015 Pg. 161-166
Return to Top